IMMUNE DESIGN CORP.

Completed

Tender offer

Sector: Healthcare
Industry: Pharmaceutical Preparations
Exchange: —
State of incorporation: DE
Form: SC TO-T/A
Filed: April 2, 2019

Deal approval & antitrust

merger-arb risk

A change of control closes only once its regulators clear it. These agencies have jurisdiction given the company's sector — track each one's docket for this deal. We link the official source; we do not assert an outcome.

FTC ↗Antitrust / competition review (Hart-Scott-Rodino)DOJ Antitrust Division ↗Antitrust / competition review (Hart-Scott-Rodino)

Filings & documents

Every entry traces to SEC EDGAR. The Information Statement is the primary source; the links below open the full filing and each company's complete filing history.

Source filing ↗SC TO-T/A · the filing we parse All documents in this filing ↗accession 0001193125-19-095230 IMMUNE DESIGN CORP. — all SEC filings ↗EDGAR company page Merck & Co., Inc. — 8-K announcements ↗where the spin-off was announced Merck & Co., Inc. — all SEC filings ↗parent EDGAR company page